Clinical Trial Update: Vascular Endothelial Growth Factor (VEGF) Imaging Before and During Everolimus Treatment for Renal Cell Carcinoma

View source ↗

Summary

A completed clinical trial evaluating VEGF imaging before and during everolimus treatment for metastatic renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Afinitor (everolimus)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Metastatic Renal Cell Carcinoma | Status: COMPLETED